Also known as: Acetyl Hexapeptide-8, Acetyl Hexapeptide-3, AH-8
Dynamic wrinkle reduction
Amount
5-10% concentration
Frequency
Once to twice daily
Duration
4-6 weeks (visible effects at 2-4 weeks)
Route
TopicalTiming
Apply to areas of dynamic wrinkles (forehead, around eyes, between brows). Gently pat to encourage absorption. Use consistently for best results.
Duration
Ongoing (continuous use for maintained benefit)
Repeatable
Yes
Skin assessment
When: Baseline
Why: Document baseline wrinkle depth and skin condition
Skin assessment
When: 4 weeks
Why: Evaluate wrinkle reduction and skin tolerance
Get free access to all content plus biweekly research updates.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Argireline is the trade name for acetyl hexapeptide-8 (formerly acetyl hexapeptide-3), a synthetic cosmetic peptide developed by Lipotec (now Lubrizol) and launched in 2001. It is one of the most widely recognized anti-aging peptides in the cosmeceutical market, often marketed as a "topical Botox alternative."
The peptide was identified through a rational design program aimed at finding compounds that could inhibit the SNARE complex responsible for synaptic vesicle fusion at the neuromuscular junction, without the toxicity associated with botulinum neurotoxin.
Argireline (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) mimics the N-terminal end of SNAP-25 (synaptosomal-associated protein of 25 kDa), one of three proteins in the SNARE complex. Its mechanism:
This mechanism is conceptually similar to botulinum toxin type A, which cleaves SNAP-25 proteolytically. However, Argireline's competitive inhibition is much milder and reversible, and its topical delivery limits penetration to superficial facial muscles.
In the original Blanes-Mira et al. study, a 10% Argireline emulsion applied daily for 30 days reduced wrinkle depth by up to 30% in healthy women volunteers. In a randomized, placebo-controlled study in Chinese subjects (Wang et al., 2013), Argireline applied twice daily for 4 weeks showed 48.9% total anti-wrinkle efficacy vs 0% for placebo, with significant decreases in roughness parameters.
Argireline is a cosmetic ingredient with topical application only. Its effects are milder than injectable botulinum toxin and limited by skin penetration challenges. The peptide is hydrophilic and relatively large (889 Da), which means penetration through the lipophilic stratum corneum is inherently limited. Results vary depending on formulation quality, concentration, and individual skin characteristics.
A Synthetic Hexapeptide (Argireline) with Antiwrinkle Activity, published in International Journal of Cosmetic Science (Blanes-Mira C et al., 2002; PMID: 18498523):
The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled Study, published in American Journal of Clinical Dermatology (Wang Y et al., 2013; PMID: 23417317):
We summarize new studies, safety updates, and dosing insights โ delivered biweekly.
See real-world usage patterns alongside the clinical evidence above. Community-sourced, not clinically verified.
Based on 120+ community reports
View community protocolsBotulinum toxin: FDA-approved neurotoxin guide. Covers SNARE mechanism, Botox vs Dysport, migraine and spasticity uses, dosing, and safety profile.
GHK-Cu: Copper tripeptide for skin healing and anti-aging. Covers collagen stimulation, wound repair, hair growth, and topical vs injectable use.
Matrixyl (palmitoyl pentapeptide-4): collagen-stimulating cosmeceutical peptide. Clinical studies show wrinkle reduction via matrikine signaling in fibroblasts.
SNAP-8: Botox-like cosmeceutical peptide for wrinkle reduction. Covers SNARE complex inhibition, topical formulation research, and Argireline comparison.
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.
Related content you may find interesting
